£78.95

Springer Improving Outcomes for Breast Cancer Survivors: Perspectives on Research Challenges and Opportunities: 862 (Advances in Experimental Medicine and Biology, 862)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£79 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£78.95 £75.00 £76.58 £78.16 £79.74 £81.32 £82.90 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 1 price levels

Days at Price
90 days 0 23 45 68 90 £79 Days at Price

Price Analysis

Most common price: £79 (90 days, 100.0%)

Price range: £79 - £79

Price levels: 1 different prices over 90 days

Description

In collaboration with the Breast Cancer Research Foundation (BCRF), this timely volume provides a comprehensive review on all areas of breast cancer survivorship research, highlighting research that is underway or in development. The range of topics covered include the biology and management of fatigue and cognitive dysfunction on breast cancer survivorship, the biology and management of Neuropathy and Arthralgias, the ongoing research on the biology of diet and lifestyle interventions in survivors, and more. With the tremendous growth in the number of breast cancer survivors, researchers have moved beyond describing the outcomes of breast cancer treatments and are focusing their research on understanding the mechanisms underlying the development of the late effects of breast cancer treatment, as well as the development and evaluation of interventions to mitigate some of the persistent symptoms―topics which are also explored in this volume. In addition, current research on how to improve survivorship and reduce recurrence of breast cancer through behavioral and lifestyle modifications is also discussed.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 October 2016
Listed Since
07 October 2016

Barcode

No barcode data available

Similar Products You Might Like

Prognostic variables in node-negative and node-positive breast cancer
85% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£171.81 18 May 2026
Health Services for Cancer Survivors: Practice, Policy and Research
83% match

Health Services for Cancer Survivors: Practice, Policy and Research

Springer

£107.98 18 May 2026
A Practical Guide to Breast Cancer Treatment
83% match

A Practical Guide to Breast Cancer Treatment

Springer

£103.00 10 May 2026
Early Onset Breast Cancer: Epidemiology, Pathobiology, Diagnosis, Treatment, and Survivorship
83% match

Early Onset Breast Cancer: Epidemiology, Pathobiology, Diagnosis, Treatment, and Survivorship

Springer

£129.99 18 May 2026
Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)
82% match

Hormone Receptors in Breast Cancer: 147 (Cancer Treatment and Research, 147)

Springer

£80.64 18 May 2026
Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)
82% match

Breast Cancer: Origins, Detection, and Treatment: Proceedings of the International Breast Cancer Research Conference London, United Kingdom ― March 24–28, 1985: 43 (Developments in Oncology, 43)

Springer

£77.95 18 May 2026
Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)
82% match

Epigenetic Mechanisms in Breast Cancer Therapy and Resistance (Advances in Experimental Medicine and Biology, 1465)

Springer

£127.59 14 May 2026
Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)
81% match

Breast Cancer: Progress in Biology, Clinical Management and Prevention: Proceedings of the International Association for Breast Cancer Research ... March 1989: 58 (Developments in Oncology, 58)

Springer

£107.98 18 May 2026
Approaches to Breast Cancer Prevention: 62 (Developments in Oncology, 62)
81% match

Approaches to Breast Cancer Prevention: 62 (Developments in Oncology, 62)

Springer

£146.35 18 May 2026
The Voice of Breast Cancer in Medicine and Bioethics: 88 (Philosophy and Medicine, 88)
81% match

The Voice of Breast Cancer in Medicine and Bioethics: 88 (Philosophy and Medicine, 88)

Springer

£113.76 11 May 2026
Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)
81% match

Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)

Springer

£66.52 17 May 2026
Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)
81% match

Adjuvant Therapy of Breast Cancer: 60 (Cancer Treatment and Research, 60)

Springer

£149.65 18 May 2026
Breast Cancer in Women of African Descent
81% match

Breast Cancer in Women of African Descent

Springer

£110.67 11 May 2026
Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook
81% match

Breast Cancer Management for Surgeons: A European Multidisciplinary Textbook

Springer

£162.32 16 May 2026
Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)
81% match

Resistance to Targeted Therapies in Breast Cancer: 16 (Resistance to Targeted Anti-Cancer Therapeutics, 16)

Springer

£79.97 18 May 2026
Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects
81% match

Nano Theragnostics in Breast Cancer: Advances, Challenges, and Future Prospects

Springer

£147.11 17 May 2026
Reproductive Health and Cancer in Adolescents and Young Adults: 732 (Advances in Experimental Medicine and Biology, 732)
80% match

Reproductive Health and Cancer in Adolescents and Young Adults: 732 (Advances in Experimental Medicine and Biology, 732)

Springer

£106.90 18 May 2026
New Trends in Cancer for the 21st Century: 587 (Advances in Experimental Medicine and Biology, 587)
80% match

New Trends in Cancer for the 21st Century: 587 (Advances in Experimental Medicine and Biology, 587)

Springer

£147.11 11 May 2026
Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)
80% match

Breast Cancer Pathophysiology: An Interdisciplinary Approach: 5 (Interdisciplinary Cancer Research, 5)

Springer

£154.66 16 May 2026
Exploring Nanocarriers in Breast Cancer Management
80% match

Exploring Nanocarriers in Breast Cancer Management

Academic Press

£137.99 11 May 2026
Bioactive Essential Oils and Cancer
79% match

Bioactive Essential Oils and Cancer

Springer

£107.98 19 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
79% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 18 May 2026
Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)
79% match

Breast Cancer, An Issue of Hematology/Oncology Clinics of North America (Volume 27-4) (The Clinics: Internal Medicine, Volume 27-4)

Elsevier

£55.45 11 May 2026
Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance
79% match

Signaling Pathways in Breast Cancer: Molecular Mechanisms, Therapeutic Strategies, and Multidrug Resistance

Academic Press

£145.99 11 May 2026